Filing Details
- Accession Number:
- 0001213900-19-021417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-29 20:27:53
- Reporting Period:
- 2019-10-25
- Accepted Time:
- 2019-10-29 20:27:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1568678 | R. Glenn Mattes | 2600 Via Fortuna, Suite 360 Austin TX 78746 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-25 | 10,000 | $5.00 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2019-10-29 | 332,868 | $0.00 | 332,868 | $5.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 945,891 | 2029-10-29 | No | 4 | A | Direct |
Footnotes
- The shares of common stock purchased in the Issuer's initial public offering.
- 25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
Billionaire Hedge Funds
